Double-digit annual growth in medical IT, endoscopy and ultrasound diagnostics

「In June 2026, we launched the EG-860Z upper gastrointestinal magnifying endoscope and the EC-860ZP/M and EC-860ZP/L lower gastrointestinal magnifying endoscopes as new additions to the gastrointestinal magnifying endoscope lineup for the LED light source-equipped ELUXEO endoscopy system.」

「In March 2026, the company launched the lightweight, compact portable X-ray system CALNEO Xair PLUS, which contributes to more efficient examination workflows, as well as the bronchoscopes EB-840S and EB-840T, equipped with HD image CMOS sensors, as new additions to its bronchoscope lineup.」

「In March 2026, we launched the CALNEO Xair PLUS, a lightweight, compact portable X-ray imaging device that contributes to more efficient examination workflows, as well as the EB-840S, EC-860ZP/M and EC-860ZP/L bronchoscopes featuring HD image CMOS sensors as new additions to the bronchoscopic lineup.」

「In August 2025, the company announced the development of a new model of a portable X-ray system that is easy to carry. Developed using AI technology, its patient-positioning support function assists with simple X-ray examinations in a wide range of settings, including home healthcare, mountainous areas and remote islands.」

「In the Medical Systems segment, the company will steadily advance its growth strategy by expanding products and services that use AI and IT, a key priority, and growing recurring businesses such as services and consumables. In the health screening services business, it established the NURA Global Innovation Center, a strategic hub in Kerala, India, in December 2024, with training for medical staff and remote image interpretation capabilities, and opened a health screening center in the United Arab Emirates in January 2025 incorporating NURA's operating expertise. The company will continue to accelerate the rollout of NURA in fiscal 2025.」

「In the Medical Systems segment, revenue increased as sales remained strong in fields including endoscopy, CT and MRI, and in vitro diagnostics (IVD). In X-ray imaging diagnostics, revenue increased due to growth in sales in Japan of the digital mammography systems Amulet SOPHINITY and Amulet ELITE, as well as the expansion of the maintenance services business, mainly in Japan and Europe, driven by higher contract rates.」

「In April 2024, the company launched SYNAPSE Creative Space, a service supporting the development of AI technology for diagnostic imaging assistance at medical and research institutions.」

「In ultrasound diagnostics, sales of the new DeepInsight series of cart-based ultrasound diagnostic systems grew mainly in Japan, but revenue declined due to weak sales in China.」

「In the Medical Systems segment, revenue increased as sales remained strong in fields including endoscopy and healthcare IT. In X-ray imaging diagnostics, revenue increased due in part to growth in sales of the digital mammography system Amulet Innovality, mainly in Latin America. In healthcare IT, sales of systems and services centered on the medical image information system (PACS) SYNAPSE and the 3D image analysis system SYNAPSE VINCENT grew mainly in the United States and Europe, resulting in higher revenue.」

「In the Medical Systems segment, revenue increased as sales remained strong in fields including endoscopy and healthcare IT. In X-ray imaging diagnostics, sales of the ultra-lightweight mobile digital X-ray system FDR nano grew mainly in Southeast Asia, while domestic sales also remained strong, resulting in higher revenue.」

「In healthcare IT, sales of systems and services centered on the medical image information system (PACS) SYNAPSE and the 3D image analysis system SYNAPSE VINCENT grew, mainly in the United States and Japan, and revenue increased substantially.」

「In the Medical Systems segment, sales remained strong, mainly in healthcare IT, endoscopy and ultrasound diagnostics, and revenue increased substantially. In X-ray imaging diagnostics, sales of the digital mammography system AMULET Innovality remained solid, mainly in the United States and emerging markets, while sales of the digital X-ray fluoroscopy system CUREVISTA Open also grew. In healthcare IT, sales of new products, including the SYNAPSE VINCENT Core software specialized in analytical functions for radiology, remained strong in addition to the medical image information system (PACS) SYNAPSE and the 3D image analysis system SYNAPSE VINCENT, resulting in substantially higher revenue mainly in the United States and Japan. In ultrasound diagnostics, in addition to growth in POC ultrasound diagnostic systems centered on Sonosite PX in the United States, Europe and elsewhere, sales of the new cart-based ultrasound diagnostic systems ARIETTA 850DI and ARIETTA 650DI increased, mainly in Japan and Europe. In endoscopy, sales of the 7000 systems and other products equipped with image-enhancement functions, including LCI (Linked Color Imaging), which accentuates subtle differences in mucosal color and supports endoscopic observation, grew substantially, mainly in the United States, Europe and Japan.」

「In the Medical Systems segment, sales remained strong, mainly in healthcare IT and endoscopy, and revenue increased. In ultrasound diagnostics, sales of the Sonosite PX ultrasound diagnostic system for point-of-care (POC) use and the cart-based ultrasound diagnostic system ARIETTA 750 increased mainly in the United States and Europe. In endoscopy, sales of the 7000 systems and other products equipped with image-enhancement functions, including LCI (Linked Color Imaging), which accentuates subtle differences in mucosal color and supports endoscopic observation, grew substantially, mainly in the United States and Europe.」

「In February 2022, the company launched the top-end Sonosite LX for point-of-care use in the United States and Australia.」

「In ultrasound diagnostics, sales of the Sonosite PX ultrasound diagnostic system for point-of-care (POC) use and the cart-based ultrasound diagnostic system ARIETTA 750 remained strong.」

「In healthcare IT, sales of systems and services centered on the medical image information system (PACS) SYNAPSE and the 3D image analysis system SYNAPSE VINCENT increased substantially, mainly in Japan, China and Europe.」

「In ultrasound diagnostics, in addition to strong sales of Sonosite PX in the United States and Europe, revenue increased as the company responded to increased demand during the COVID-19 pandemic, including in Japan.」

「In X-ray imaging diagnostics, strong demand for the mobile digital X-ray systems FUJIFILM DR CALNEO AQRO and FUJIFILM DR CALNEO Go PLUS continued, and sales remained strong in Europe, the United States, Asia, Latin America and the Middle East and Africa. In ultrasound diagnostics, sales remained strong for the high-end ultrasound imaging system Sonosite PX, launched in the United States in July 2020 and in Europe in August of the same year.」

「In X-ray imaging diagnostics, demand for the mobile digital X-ray systems FUJIFILM DR CALNEO AQRO and FUJIFILM DR CALNEO Go PLUS, which can capture images while being moved between beds in hospital rooms, surged, and sales grew in Asia, Latin America and the Middle East and Africa in addition to Europe and the United States. In ultrasound diagnostics, demand for examinations and procedures related to pneumonia also surged, and sales grew for portable ultrasound imaging systems such as the SonoSite Edge II, which can be easily carried to patients' bedsides.」

「Demand for mobile X-ray systems capable of imaging while moving between multiple hospital beds surged due to the COVID-19 pandemic, and sales grew mainly in Europe and the United States.」

「In December 2019, the company began selling in Japan the wireless ultrasound imaging system iViz air, which combines a palm-sized compact design with high image quality.」

「In July 2019, the company also began selling in Japan the AI platform SYNAPSE SAI viewer, which uses AI technology to support diagnosis, including automatic extraction of organs from CT images.」

「In the Medical Systems segment, sales remained strong in fields including healthcare IT and endoscopy, and revenue increased. In X-ray imaging diagnostics, sales of the FUJIFILM DR CALNEO Smart series of digital X-ray imaging systems remained solid, mainly in emerging markets such as the Middle East and Africa. In healthcare IT, sales of systems centered on the medical image information system (PACS) SYNAPSE remained strong, mainly in Japan and the United States. In endoscopy, sales of the 7000 systems and other products capable of the company's proprietary special-light observation remained strong. In May 2019, the company announced the acquisition of medwork, which develops, manufactures and sells endoscopic accessories, marking its full-scale entry into the endoscopic accessories business.」

「In the Medical Systems segment, sales remained strong across all fields, including X-ray imaging diagnostics, healthcare IT, endoscopy, ultrasound and in vitro diagnostics (IVD), and revenue increased. In X-ray imaging diagnostics, domestic sales of the portable X-ray system CALNEO Xair, which is easy to carry, began in October 2018.」

「In the Medical Systems segment, sales remained strong, particularly in X-ray imaging diagnostics and endoscopy, and revenue increased overall. In X-ray imaging diagnostics, sales of the ultra-lightweight mobile digital X-ray system FUJIFILM DR CALNEO AQRO remained strong, mainly in overseas markets. The company is also working to strengthen sales of COREVISION 3D, a surgical C-arm digital fluoroscopy system launched in June 2018 that enables users to view the target area in 3D during surgery and supports more accurate procedures. In healthcare IT, sales of systems centered on the medical image information system (PACS) SYNAPSE remained strong, mainly in Japan and the United States. In endoscopy, sales of the LASEREO series, which enables the company's proprietary special-light observation, remained strong. In ultrasound diagnostics, sales of a range of products, including the fully flat ultrasound imaging system SonoSite S II and the portable ultrasound imaging system SonoSite Edge II, remained strong in Europe and Asia as well as the United States. In the in vitro diagnostics (IVD) field, sales of the Drychem series blood testing systems remained strong both in Japan and overseas.」

「In the Medical Systems segment, sales remained strong in fields including X-ray imaging diagnostics, endoscopy and in vitro diagnostics (IVD), and revenue increased. In X-ray imaging diagnostics, sales of the ultra-lightweight mobile digital X-ray system FUJIFILM DR CALNEO AQRO remained strong. In June 2018, the company launched COREVISION 3D, a surgical C-arm digital fluoroscopy system that enables surgeons to view 3D images during surgery and supports more accurate procedures.」

「In the Medical Systems segment, sales remained strong across all fields, including X-ray imaging diagnostics, healthcare IT, endoscopy, ultrasound and in vitro diagnostics (IVD), and revenue increased.」

「In the ultrasound diagnostics field, sales of the premium SonoSite X-Porte, which meets clinical needs for cardiovascular diagnosis in emergency care, expanded mainly in the United States and also in the Middle East. Sales of the portable ultrasound imaging system SonoSite Edge II and the fully flat ultrasound imaging system SonoSite S II also remained strong. Orders for the compact, lightweight tablet-type ultrasound imaging system SonoSite iViz expanded in emerging markets such as Eastern Europe and South America, in addition to developed markets in Japan, the United States and Europe.」

「In the Medical Systems segment, sales remained strong in major fields including in vitro diagnostics (IVD) systems and endoscopy, and revenue increased. In ultrasound diagnostics, sales of the premium SonoSite X-Porte, designed to meet clinical needs for cardiovascular diagnosis in emergency care, expanded mainly in the United States.」

「In the Medical Systems segment, sales remained solid in all major areas, including in vitro diagnostics (IVD) systems, endoscopy and other fields, and revenue increased. In the X-ray imaging diagnostics field, sales of the ultra-lightweight mobile digital X-ray system FUJIFILM DR CALNEO AQRO, which is compact and approximately one-fifth the weight of the previous model, remained strong. In healthcare IT, sales of systems centered on the medical image information system (PACS) SYNAPSE remained strong. In endoscopy, sales of the LASEREO series, which uses two different types of laser as its light source, remained strong. In ultrasound diagnostics, sales of a series of new products, including the portable ultrasound imaging system SonoSite Edge II, the fully flat ultrasound imaging system SonoSite S II and the compact, lightweight tablet-type ultrasound imaging system SonoSite iViz, which began rolling out in various countries from the end of fiscal 2015, continued to remain strong.」

「In the ultrasound diagnostics field, sales remained solid for a series of new products, including the portable ultrasound imaging system SonoSite Edge II, launched successively in various countries from January 2016; the fully flat ultrasound imaging system SonoSite S II; and the compact, lightweight tablet-type ultrasound imaging system SonoSite iViz. In particular, domestic sales of SonoSite iViz remained strong and contributed to higher revenue.」

「In the Medical Systems segment, sales of in vitro diagnostics (IVD) systems, a growth area, remained strong, but revenue declined due to the impact of the yen's appreciation and other factors.」

「Although sales in growth areas such as healthcare IT remained solid, revenue declined due to the impact of the yen's appreciation and other factors.」

「Although sales in growth areas such as healthcare IT remained solid, revenue declined due to the impact of the yen's appreciation and other factors. In the endoscopy field, sales remained solid for the LASEREO laser endoscopy system, equipped with a high-resolution CMOS sensor and laser light source, as well as new ultrasound endoscopy systems. In the ultrasound diagnostics field, domestic sales of the compact, lightweight tablet-type ultrasound imaging system SonoSite iViz began in May 2016, strengthening the product lineup.」

「We will further strengthen healthcare IT, endoscopy, and ultrasound diagnostics to achieve growth. In healthcare IT, we aim to expand revenue at a double-digit annual rate by providing high-value-added systems that support the efficient management and diagnosis of medical images. In endoscopy, we will introduce distinctive products such as transnasal endoscopes and models equipped with laser light sources. In ultrasound diagnostics, we will expand sales of portable diagnostic devices, for which further market expansion is expected.」